Lisa Flynn

Oral Proteasome Inhibitor Ixazomib for Switch-Maintenance Prophylaxis of Recurrent or Late Acute and Chronic Graft-versus-Host Disease after Day 100 in Allogeneic Stem Cell Transplantation.

M. Perales, S. Devlin, S. Giralt, 2021, Transplantation and cellular therapy.

High progression-free survival after intermediate intensity double unit cord blood transplantation in adults.

M. Perales, S. Devlin, K. Hsu, 2020, Blood advances.

Real-time Reflectance Confocal Microscopy of Cutaneous Graft-versus-Host Disease Correlates with Histopathology.

S. Dusza, M. Ardigó, J. Monnier, 2021, Transplantation and cellular therapy.

Understanding cognitive and emotional illness representations of South Asian head and neck cancer survivors: a qualitative study

Smita C. Banerjee, J. Ostroff, M. Camacho-Rivera, 2019, Ethnicity & health.